These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

405 related articles for article (PubMed ID: 35372875)

  • 1. Predictors of Arteriovenous Fistula Failure: A
    See YP; Cho Y; Pascoe EM; Cass A; Irish A; Voss D; Polkinghorne KR; Hooi LS; Ong LM; Paul-Brent PA; Kerr PG; Mori TA; Hawley CM; Johnson DW; Viecelli AK
    Kidney360; 2020 Nov; 1(11):1259-1269. PubMed ID: 35372875
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of Fish Oil Supplementation and Aspirin Use on Arteriovenous Fistula Failure in Patients Requiring Hemodialysis: A Randomized Clinical Trial.
    Irish AB; Viecelli AK; Hawley CM; Hooi LS; Pascoe EM; Paul-Brent PA; Badve SV; Mori TA; Cass A; Kerr PG; Voss D; Ong LM; Polkinghorne KR;
    JAMA Intern Med; 2017 Feb; 177(2):184-193. PubMed ID: 28055065
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparison of arteriovenous fistula failure between Malaysian and Australian and New Zealand participants enrolled in the FAVOURED trial.
    Hudson R; Pascoe EM; See YP; Cho Y; Polkinghorne KR; Paul-Brent PA; Hooi LS; Ong LM; Mori TA; Badve SV; Cass A; Kerr PG; Voss D; Hawley CM; Johnson DW; Irish AB; Viecelli AK
    J Vasc Access; 2024 Jan; 25(1):193-202. PubMed ID: 35686506
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Omega-3 fatty acids (Fish Oils) and Aspirin in Vascular access OUtcomes in REnal Disease (FAVOURED) study: the updated final trial protocol and rationale of post-initiation trial modifications.
    Viecelli AK; Pascoe E; Polkinghorne KR; Hawley C; Paul-Brent PA; Badve SV; Cass A; Heritier S; Kerr PG; Mori TA; Robertson A; Seong HL; Irish AB;
    BMC Nephrol; 2015 Jun; 16():89. PubMed ID: 26116581
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fish oil and aspirin effects on arteriovenous fistula function: Secondary outcomes of the randomised omega-3 fatty acids (Fish oils) and Aspirin in Vascular access OUtcomes in REnal Disease (FAVOURED) trial.
    Viecelli AK; Polkinghorne KR; Pascoe EM; Paul-Brent PA; Hawley CM; Badve SV; Cass A; Hooi LS; Kerr PG; Mori TA; Ong LM; Voss D; Johnson DW; Irish AB;
    PLoS One; 2019; 14(3):e0213274. PubMed ID: 30913208
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Determinants of venous catheter hemodialysis onset and subsequent switch to arteriovenous fistula: An epidemiological study in Lazio region.
    Tazza L; Angelici L; Marino C; Di Napoli A; Bossola M; De Cicco C; Davoli M; Agabiti N
    J Vasc Access; 2021 Sep; 22(5):749-758. PubMed ID: 32993439
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Trends in US Vascular Access Use, Patient Preferences, and Related Practices: An Update From the US DOPPS Practice Monitor With International Comparisons.
    Pisoni RL; Zepel L; Port FK; Robinson BM
    Am J Kidney Dis; 2015 Jun; 65(6):905-15. PubMed ID: 25662834
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Factors associated with functional arteriovenous fistula at hemodialysis start and arteriovenous fistula non-use in a single-center cohort.
    Chung EY; Knagge D; Cheung S; Sun J; Heath L; McColl H; Guo H; Gray L; Srivastava T; Sandy J; McGinn S; Fisher C
    J Vasc Access; 2022 Jul; 23(4):558-566. PubMed ID: 33752497
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Catheter Dependence After Arteriovenous Fistula or Graft Placement Among Elderly Patients on Hemodialysis.
    Lyu B; Chan MR; Yevzlin AS; Astor BC
    Am J Kidney Dis; 2021 Sep; 78(3):399-408.e1. PubMed ID: 33582176
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Provision of Kidney Disease Education Service Is Associated with Improved Vascular Access Outcomes among US Incident Hemodialysis Patients.
    Ruchi R; Bozorgmehri S; Chamarthi G; Orozco T; Mohandas R; Ozrazgat-Baslanti T; Segal MS; Shukla AM
    Kidney360; 2022 Jan; 3(1):91-98. PubMed ID: 35368570
    [TBL] [Abstract][Full Text] [Related]  

  • 11. International Comparisons of Native Arteriovenous Fistula Patency and Time to Becoming Catheter-Free: Findings From the Dialysis Outcomes and Practice Patterns Study (DOPPS).
    Pisoni RL; Zepel L; Zhao J; Burke S; Lok CE; Woodside KJ; Wasse H; Kawanishi H; Schaubel DE; Zee J; Robinson BM
    Am J Kidney Dis; 2021 Feb; 77(2):245-254. PubMed ID: 32971192
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Outcomes of initial hemodialysis vascular access in patients initiating dialysis with a tunneled catheter.
    Copeland T; Lawrence P; Woo K
    J Vasc Surg; 2019 Oct; 70(4):1235-1241. PubMed ID: 31147122
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Arteriovenous Access Type and Risk of Mortality, Hospitalization, and Sepsis Among Elderly Hemodialysis Patients: A Target Trial Emulation Approach.
    Lyu B; Chan MR; Yevzlin AS; Gardezi A; Astor BC
    Am J Kidney Dis; 2022 Jan; 79(1):69-78. PubMed ID: 34118301
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationships Between Clinical Processes and Arteriovenous Fistula Cannulation and Maturation: A Multicenter Prospective Cohort Study.
    Allon M; Imrey PB; Cheung AK; Radeva M; Alpers CE; Beck GJ; Dember LM; Farber A; Greene T; Himmelfarb J; Huber TS; Kaufman JS; Kusek JW; Roy-Chaudhury P; Robbin ML; Vazquez MA; Feldman HI;
    Am J Kidney Dis; 2018 May; 71(5):677-689. PubMed ID: 29398178
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Arteriovenous Fistula Maturation in Prevalent Hemodialysis Patients in the United States: A National Study.
    Woodside KJ; Bell S; Mukhopadhyay P; Repeck KJ; Robinson IT; Eckard AR; Dasmunshi S; Plattner BW; Pearson J; Schaubel DE; Pisoni RL; Saran R
    Am J Kidney Dis; 2018 Jun; 71(6):793-801. PubMed ID: 29429750
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of a More Selective Arteriovenous Fistula Strategy on Vascular Access Outcomes.
    Allon M; Al-Balas A; Young CJ; Cutter GR; Lee T
    J Am Soc Nephrol; 2023 Sep; 34(9):1589-1600. PubMed ID: 37401775
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical Outcomes of Arteriovenous Access in Incident Hemodialysis Patients with Medicare Coverage, 2012-2014.
    Bylsma LC; Reichert H; Gage SM; Roy-Chaudhury P; Nordyke RJ; Fryzek J; Dahl SLM; Lithgow T; Lawson JH
    Am J Nephrol; 2019; 49(2):156-164. PubMed ID: 30677763
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment of Use of Arteriovenous Graft vs Arteriovenous Fistula for First-time Permanent Hemodialysis Access.
    Hicks CW; Wang P; Kernodle A; Lum YW; Black JH; Makary MA
    JAMA Surg; 2019 Sep; 154(9):844-851. PubMed ID: 31188411
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Costs Attributable to Arteriovenous Fistula and Arteriovenous Graft Placements in Hemodialysis Patients with Medicare coverage.
    Nordyke RJ; Reichert H; Bylsma LC; Jackson JJ; Gage SM; Fryzek J; Roy-Chaudhury P; Lithgow T
    Am J Nephrol; 2019; 50(4):320-328. PubMed ID: 31434095
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sex Disparities in Arteriovenous Fistula Maturation Outcomes.
    Hoffstaetter T; Silpe J; Delijani D; Landis GS; Etkin Y
    Ann Vasc Surg; 2023 Sep; 95():197-202. PubMed ID: 37270092
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.